Ahmedabad: The two-day national conference (NATCON) 2025 of the Indian Medical Association (IMA) in the city concluded on ...
Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the following investor ...
SAN DIEGO, October 31, 2025--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a ...
SAN FRANCISCO, June 20, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...
– Hengrui to present six abstracts highlighting clinical progress of GLP-1/GIP dual receptor agonist HRS9531 (KAI-9531) and GLP-1 receptor agonist HRS-7535 (KAI-7535) in type 2 diabetes and obesity – ...
The MarketWatch News Department was not involved in the creation of this content. GAITHERSBURG, Md., June 13, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage ...
Studies underscore advances in screening, mental health, health equity, and early intervention in diabetes care. New study examines benefits of continuous glucose monitoring (CGM) in people with type ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback